Children's Colorado wins $50,000 funding from Patient-Centered Outcomes Research Institute

NewsGuard 100/100 Score

Children's Hospital Colorado (Children's Colorado) has been approved for a $50,000 funding award by the Patient-Centered Outcomes Research Institute (PCORI) to support a project on developing effective interventions to achieve a healthy weight among Hispanic children ages 0-5.

Children's Colorado will use the funds provided through PCORI's Pipeline to Proposal Awards program to continue building the Familias Saludables partnership, which has successfully engaged Hispanic parents/caregivers of young children, clinicians, researchers and community partners.

"With this award, our Familias Saludables partnership will further strengthen engagement and capacity across stakeholders to conduct patient-centered comparative effectiveness research in the future," said Deb Federspiel, senior strategist in the Child Health Advocacy Institute at Children's Colorado. "Our long-term goal is to apply learnings to design culturally-tailored interventions that will ultimately advance the health of Hispanic children."

Pipeline to Proposal Awards enable individuals and groups that are not typically involved in clinical research to develop community-led funding proposals focused on patient-centered comparative effectiveness research.

Established by the nonprofit PCORI, the program funds help individuals or groups build community partnerships, develop research capacity, and hone a comparative effectiveness research question that could become the basis of a research funding proposal to submit to PCORI or other health research funders.

"Our engagement work with stakeholders, including families, is incredibly important. Research stemming from this work will, as a result, be more innovative, and hopefully more relevant to the concerns of the Hispanic community," said Darcy Thompson, MD, MPH, associate professor of pediatrics and research lead/principal investigator.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease